Introduction
Aliskiren, (2(S), 4(S), 5(S), 7(S)-N-(2-carbamoyl-2-methylpropyl) -5-amino-4-hydroxy2,7 diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl] octanamide hemifumarate) 1-3 ( Fig. 1) . The first oral direct renin inhibitor approved for clinical use, exhibits a novel and advantageous pharmacokinetic and pharmacodynamic profile for the long-term treatment of hypertension. Aliskiren blocks the renin system at its rate-limiting step by directly inhibiting the catalytic activity of renin, thereby reducing generation of angiotensin I and angiotensin II.
Amlodipine, 2[(2-aminoethoxy) methyl]-4-(2-chloro-phenyl)-1, 4-dihydro-6-methyl-3, 5-pyridine carboxylic acid, 3-ethyl, 5-methylester is a dihydro pyridine (Fig. 2 ) derivative with calcium antagonist activity. It is used in the management of hypertension, chronic stable angina pectoris and prinzmetal variant angina. Amlodipine inhibits the trans-membrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Hydrochlorothiazide belongs to Thiazide class of diuretics, acting on the kidneys to reduce sodium (Na) reabsorption in the distal convoluted tubule. This increases the osmolarity in the lumen, causing less water to be reabsorbed by the collecting ducts. This leads to increase urinary output. It is chemically 6-chloro-1, 1-dichloro-3, 4,dihydro -2H-1, 2, 4-benzoliadiazine-7-sulphanomide1, 1-dioxide (Fig. 3) .
Literature survey revealed HPLC [1] , LC-MS [2] , spectroflurimetric and simultaneous UVspectrophotometric methods are reported for the estimation of aliskiren hemifumarate [3] [4] , amlodipine [5] [6] [7] [8] [9] [10] , hydrochlorothiazide [11] [12] [13] [14] [15] alone or in combination with other anti-hypertensive agents. So the present study aim to develop a simple, selective and precise RP-HPLC method was developed for the simultaneous estimation of Aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide in bulk drug and in combined dosage form. 
II.
Materials And Methods
Chromatographic Conditions
The Waters HPLC with PDA detector and Empower 2 software was employed for the present study. The chromatography determination performed at ambient temperature by using Inertsil-ODS, C18, 100 X 4.6, 5μm) column, with a mobile phase composed of 0.1M ammonium acetate: Acetonitrile in the ratio 65:35 (v/v). pH of the buffer was adjusted to 5 using formic acid. The chromatography run time was maintained up to 10.0 min with flow rate at 1.0 mL / min with injection volume 20μL and the eluent was monitored at 232 nm.
Reference Standards, Reagents
The standard Aliskiren hemifumarate was obtained from Mylan Pharmaceuticals, Hyderabad. Amlodipine and Hydrochlorothiazide were procured from Life Care Pharmaceutical Industries, Pondicherry. Amturnide tablets were procured from US market. Acetonitrile and water employed for the preparation of mobile phase were of HPLC grade was obtained from Merck limited, Mumbai.
Preparation of standard solutions
Weigh and transfer 12.5 mg of Hydrochlorothiazide, 150 mg of Aliskiren and 5 mg of Amlodipine working standard into 100 mL volumetric flask, add 50 mL of diluent and sonicate and make up to the volume with diluent. Transfer 10 mL of standard stock solution into 100 mL volumetric flask and dilute it with diluent.
Preparation of Sample Solutions
20 tablets (Amturnide) were taken and finely powdered. Powder equivalent to 12.5 mg of Hydrochlorothiazide,150 mg of Aliskiren and 5 mg of Amlodipine was taken in to a 100 mL volumetric flask add 50 mL of diluent, sonicate for 10 minutes and make up the volume. Further filter the solution through 0.45 µ membrane filter paper. Dilute 10 ml of filtrate to 100 ml with mobile phase.
Assay procedure
In case of marketed formulations, twenty tablet were taken and finely powdered. Powder equivalent to 12.5 mg of Hydrochlorothiazide, 150 mg of Aliskiren and 5 mg of Amlodipine were taken in to a 100 mL volumetric flask add 50 mL of diluent, sonicate for 10 minutes and make up the volume.The column was equilibrated for 30min, with the mobile phase flowing through the system with a flow rate of 1.0 ml/min and detector was set at a wavelength of 232nm. The retention time of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide were found to be 3.90, 5.22, 1.91min (Fig. 4) respectively in bulk drug and the retention time of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide were found to be 3.90, 5.22, 1.91 min (Fig. 5 ) respectively in pharmaceutical formulation. The blank chromatogram is shown in Fig. 6 . The % purity of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide in tablet dosage form were compiled and reported in " Table 1 ". 
Method Validation
After the method conditions were established as described above, method was validated as per ICH guidelines. The accuracy, precision, Linearity, limit of detection (LOD) and quantification (LOQ) were determined. These values are summarized in Table 10 .
Accuracy
Accuracy was determined in terms of percentage recovery. Sample solution spiked with the analytes at three different concentration levels 37.5-225.00µg/ml of Aliskiren hemifumarate, 3.125-18.75 µg/ml of Hydrochlorothiazide and 1.25-7.50µg/ml of Amlodipine. Another set of standard mixtures at the same concentration levels were also prepared with the diluents. Sample and standard solutions were injected into the HPLC system. Percentage recoveries of Aliskiren hemifumarate, Hydrochlorothiazide and Amlodipine were calculated. The values are summarized in Table 2 . 
Precision
Method precision was determined both in terms of repeatability (injection and analysis) and intermediate precision (intra-day and inter-days reproducibility). In order to determine injection repeatability, samples spiked with Aliskiren hemifumarate, hydrochlorothiazide and amlodipine were injected 6 times into HPLC system and repeatability of the retention time and peak area were determined and expressed as mean and %RSD calculated from the data obtained. The values are summarized in Table 3 , 4, 5 and 6. 
Linearity
The linearity of the method was established by spiking a series of standard mixtures of Aliskiren hemifumarate (37.5-225.00μg/ml), Hydrochlorothiazide (3.125-18.75μg/ ml) and Amlodipine (1.25-7.50μg/ml) and the above solutions are injected onto the HPLC system. The standard Calibration curve for Aliskiren hemifumarate (Fig. 8) , Amlodipine (Fig. 9) and Hydrochlorothiazide ( Fig. 10) was constructed by plotting their response ratios (ratios of the peak area of the analytes) against their respective concentrations. Linear regression was applied and slopes (a), intercept (b), correlation coefficient (r) were determined. The values are summarized in Table 7 . 
Limit of detection & Limit of quantification
Detection and quantification limits were determined through dilution method using S/N approach by injecting a 20μl sample. LOD was considered as the minimum concentration with a signal to noise ratio of atleast three (S/N˜3), while LOQ was taken as a minimum concentration with a signal to noise ratio of atleast ten (S/N˜10). The LOD for Aliskiren, Hydrochlorothiazide, Amlodipine standard solutions were found to be 2.886 ng/ml , 2.98 ng/ml and 2.99ng/ml respectively. The LOQ for Aliskiren, Hydrochlorothiazide, Amlodipine standard solutions were found to be 9.79ng/ml, 10.001ng/ml and 9.98ng/ml respectively (Table 10 ).
Robustness
As defined by ICH, The robustness of an analytical procedure describes to its capability to remain unaffected by small and deliberate variations in method parameters. Robustness was performed by small variation in the chromatographic conditions and found to be unaffected by small variations like flow rate (±10%), column oven temperature (±5°c) and wave length (±5 units). The values are summarized in Table 8 . 
Ruggedness
The method is rugged by different analyst, different time intervals and the method did not significantly affect the recoveries, peak area and retention time of all the above drugs indicating that the proposed method is rugged. The values are summarized in Table 9 . 
IV. Forced Degradation Studies (Stress Testing)
Forced degradation studies were carried out for all the three drugs. The bulk drugs were subjected to alkaline studies by adding 1.0 ml of 0.1M NaOH for 4hrs, 8hrs and 12hrs neutralized with 1.0 ml of 0.1M HCl acid. Similarly, the acidic studies were performed by adding 1.0 ml of 0.1 M HCl for 4hrs, 8hrs and 12hrs and neutralized with 1ml of 0.1M NaOH. Oxidation studies were performed on bulk drug by adding 1.0 ml of 3% H 2 O 2 , thermal studies were performed by keeping the drug at 100˚C and UV studies were performed with UVLamp for 4hrs, 8hrs and 12hrs respectively (Figure 11 -15 ). All samples were taken in different 10 ml volumetric flask and dissolved in mobile phase. Final assay drug concentration was made up with mobile phase and injected in the chromatographic system. For all the stability study, the formation of degradable product was confirmed by comparing to chromatogram of the solution kept under normal conditions. All stressed samples were analyzed by developed HPLC method. The degradation data for Aliskiren hemifumarate, Amlodipine besylate and Hydrochlorothiazide was shown in Table 11 
V. Conclusion
A novel, simple, rapid and cost effective RP-HPLC method was successfully developed for simultaneous determination of Aliskiren Hemifumarate, amlodipine besylate and hydrochlorothiazide. The proposed method was optimized and validated for the various experimental parameters. Influence of pH of the mobile phase, column oven temperature and various particulate columns on the analysis of Aliskiren Hemifumarate, amlodipine besylate and hydrochlorothiazide was evaluated. All the analytes were well resolved and separated in less than 10 min. The developed method is a stability indicating method and can be conveniently used by quality control outfits to determine the contents of Aliskiren Hemifumarate, amlodipine besylate and hydrochlorothiazide simultaneously in routine and stability samples. This method could be used for the analysis of the drugs in pharmaceutical preparations and routine laboratory analysis with slight modification in the extraction procedure. Overall, the proposed method provides high throughput for simultaneous determination of Aliskiren Hemifumarate, amlodipine besylate and hydrochlorothiazide with excellent accuracy, precision, selectivity and reproducibility.
